Buskens CJ - Search Results

1

Cyclooxygenase-2 and gastric carcinogenesis.

Saukkonen K, Rintahaka J, Sivula A, Buskens CJ, Van Rees BP, Rio MC, Haglund C, Van Lanschot JJ, Offerhaus GJ, Ristimaki A. Saukkonen K, et al. Among authors: buskens cj. APMIS. 2003 Oct;111(10):915-25. doi: 10.1034/j.1600-0463.2003.1111001.x. APMIS. 2003. PMID: 14616542 Review.

2

Prognostic role of cyclooxygenase-2 in neoadjuvant-treated patients with squamous cell carcinoma of the esophagus.

Sivula A, Buskens CJ, van Rees BP, Haglund C, Offerhaus GJ, van Lanschot JJ, Ristimäki A. Sivula A, et al. Among authors: buskens cj. Int J Cancer. 2005 Oct 10;116(6):903-8. doi: 10.1002/ijc.21134. Int J Cancer. 2005. PMID: 15856454 Clinical Trial.

3

Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus.

Buskens CJ, Van Rees BP, Sivula A, Reitsma JB, Haglund C, Bosma PJ, Offerhaus GJ, Van Lanschot JJ, Ristimäki A. Buskens CJ, et al. Gastroenterology. 2002 Jun;122(7):1800-7. doi: 10.1053/gast.2002.33580. Gastroenterology. 2002. PMID: 12055587

4

Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus.

Buskens CJ, Sivula A, van Rees BP, Haglund C, Offerhaus GJ, van Lanschot JJ, Ristimäki A. Buskens CJ, et al. Gut. 2003 Dec;52(12):1678-83. doi: 10.1136/gut.52.12.1678. Gut. 2003. PMID: 14633942 Free PMC article.

5

Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma.

Buskens CJ, Ristimäki A, Offerhaus GJ, Richel DJ, van Lanschot JJ. Buskens CJ, et al. Scand J Gastroenterol Suppl. 2003;(239):87-93. doi: 10.1080/00855920310002753. Scand J Gastroenterol Suppl. 2003. PMID: 14743889 Review.

6

Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.

Tuynman JB, Buskens CJ, Kemper K, ten Kate FJ, Offerhaus GJ, Richel DJ, van Lanschot JJ. Tuynman JB, et al. Among authors: buskens cj. Ann Surg. 2005 Dec;242(6):840-9, discussion 849-50. doi: 10.1097/01.sla.0000189546.77520.ef. Ann Surg. 2005. PMID: 16327494 Free PMC article.

7

A genetically retargeted adenoviral vector enhances viral transduction in esophageal carcinoma cell lines and primary cultured esophageal resection specimens.

Buskens CJ, Marsman WA, Wesseling JG, Offerhaus GJ, Yamamoto M, Curiel DT, Bosma PJ, van Lanschot JJ. Buskens CJ, et al. Ann Surg. 2003 Dec;238(6):815-24; discussion 825-6. doi: 10.1097/01.sla.0000098622.47909.c0. Ann Surg. 2003. PMID: 14631218 Free PMC article.

8

Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features.

Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, ten Kate FJ, van Lanschot JJ. Buskens CJ, et al. Gastrointest Endosc. 2004 Nov;60(5):703-10. doi: 10.1016/s0016-5107(04)02017-6. Gastrointest Endosc. 2004. PMID: 15557945

9

The current state of cancer gene therapy and its application in esophageal carcinoma.

Buskens CJ, Marsman WA, Bosma PJ, van Lanschot JJ. Buskens CJ, et al. Dig Surg. 2005;22(4):222-33. doi: 10.1159/000088052. Epub 2005 Sep 20. Dig Surg. 2005. PMID: 16174979 Review.

10

Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus.

Buskens CJ, Hulscher JB, van Gulik TM, Ten Kate FJ, van Lanschot JJ. Buskens CJ, et al. J Surg Res. 2006 Oct;135(2):337-44. doi: 10.1016/j.jss.2006.04.023. Epub 2006 Aug 22. J Surg Res. 2006. PMID: 16926029

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters